Spots Global Cancer Trial Database for squamous cell carcinoma of the oropharynx
Every month we try and update this database with for squamous cell carcinoma of the oropharynx cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | NCT03370276 | Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Head and Neck S... Squamous Cell C... Head and Neck C... | Nivolumab Cetuximab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma | NCT01586182 | Squamous Cell C... | Stereotactic Bo... | 18 Years - 80 Years | Dana-Farber Cancer Institute | |
| Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer | NCT00195078 | Head and Neck C... | ZD1839 (IRESSA) Cisplatin Radiation Thera... | 18 Years - | Weill Medical College of Cornell University | |
| Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery | NCT06112535 | Squamous Cell C... Squamous Cell C... | Versius Surgica... | 18 Years - | CMR Surgical Ltd | |
| Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer | NCT03224000 | Malignant Neopl... Oropharyngeal C... | Modified Barium... Swallowing Ques... Symptom Questio... Video-Strobe Pr... MRI Guided Inte... Standard-of-Car... Intensity Modul... | 18 Years - | M.D. Anderson Cancer Center | |
| Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx | NCT02552550 | Squamous Cell C... | Ability to swal... | 18 Years - 70 Years | Centre Hospitalier Universitaire de Saint Etienne | |
| Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus | NCT05918510 | Squamous Cell C... Carcinomas of U... High-risk Human... Liquid Biopsy Lymph Node Meta... Occult Tumor of... | Study of Viral ... | 18 Years - | Regina Elena Cancer Institute | |
| Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma | NCT05119036 | Squamous Cell C... HPV Positive Or... | 44 doses of rad... 54 doses of rad... | - | Indiana University | |
| Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | NCT01156142 | Head and Neck C... Mucositis Oral Complicati... Pain | doxepin hydroch... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT) | NCT04104945 | Squamous Cell C... | De-intensified ... | 18 Years - | AHS Cancer Control Alberta | |
| Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus | NCT05918510 | Squamous Cell C... Carcinomas of U... High-risk Human... Liquid Biopsy Lymph Node Meta... Occult Tumor of... | Study of Viral ... | 18 Years - | Regina Elena Cancer Institute | |
| Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies | NCT06061705 | Squamous Cell C... | Tumor Biopsy | 18 Years - | Fondation Hôpital Saint-Joseph | |
| A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC | NCT03669718 | Squamous Cell C... HPV16 Positive | ISA101b Cemiplimab Placebo | 18 Years - | ISA Pharmaceuticals | |
| De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck | NCT06030440 | Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... | Eliminating RT ... RT standard of ... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life | NCT01181648 | Squamous Cell C... | questionnaire a... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma | NCT05119036 | Squamous Cell C... HPV Positive Or... | 44 doses of rad... 54 doses of rad... | - | Indiana University | |
| Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC | NCT05608369 | HPV-Related Squ... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... | Cisplatin Radiation thera... Vorinostat | 18 Years - | Case Comprehensive Cancer Center | |
| Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer | NCT05540899 | Head and Neck C... Head and Neck S... Squamous Cell C... Squamous Cell C... Squamous Cell C... | Hypofractionate... | 18 Years - 75 Years | American College of Radiology | |
| A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck | NCT01921426 | Squamous Cell C... Squamous Cell C... | GC4419 | 18 Years - | Galera Therapeutics, Inc. | |
| Safety and Efficacy of APG-157 in Head and Neck Cancer | NCT05312710 | Head and Neck C... Squamous Cell C... Squamous Cell C... | APG-157 | 18 Years - | Aveta Biomics, Inc. | |
| A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze) | NCT05894083 | Oropharyngeal C... Squamous Cell C... | Surgery Chemoradiation Observation Post-operative ... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Saliva-based Detection of CD44 | NCT03148665 | Oral Cavity Squ... Oropharynx Squa... Squamous Cell C... Squamous Cell C... | OncAlert | 18 Years - | University of California, San Diego | |
| Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients | NCT01663259 | Squamous Cell C... HPV | Cetuximab Radiotherapy | 18 Years - | University of Michigan Rogel Cancer Center | |
| HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma | NCT05962242 | Squamous Cell C... | Radiation Thera... | 18 Years - | University of Virginia | |
| De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck | NCT06030440 | Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... | Eliminating RT ... RT standard of ... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma | NCT04031534 | Squamous Cell C... | F-Miso PET scan... | 18 Years - | Centre Henri Becquerel | |
| Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | NCT01156142 | Head and Neck C... Mucositis Oral Complicati... Pain | doxepin hydroch... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma | NCT05962242 | Squamous Cell C... | Radiation Thera... | 18 Years - | University of Virginia |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
